ALK	anaplastic lymphoma kinase
ASPS	alveolar soft part sarcoma
CDK4	cyclin-dependent kinase 4
EMA	European Medicines Agency
EORTC	European Organisation for Research and Treatment of Cancer
FDA	Food and Drug Administration
GIST	gastrointestinal stromal tumor
IGF1-R	insulin-like growth factor 1 receptor
IMT	inflammatory myofibroblastic tumor
MDM2	murine double minute 2
MSI	microsatellite instability
MPNST	malignant peripheral nerve sheath tumor
mTOR	mammalian target of rapamycin
NGS	next generation sequencing
NTRK	neurotrophic receptor kinase
OS	overall survival
PDGFR	platelet-derived growth factor receptor
PD-L1	programmed death ligand-1
PEComa	perivascular epithelioid cell tumor
PFS	progression-free survival
PI3K	phosphatidylinositol 3-kinase
STS	soft tissue sarcoma
TKI	tyrosine kinase inhibitor
TMB	tumor mutation burden
UPS	undifferentiated pleomorphic sarcoma
VEGF	vascular endothelial growth factor
XPO1	exportin-1